Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT study

• Published in: The journal of nervous and mental disease Vol. 201; no. 4; p. 266
• Main Authors: Gelenberg, Alan J, Dunner, David L, Rothschild, Anthony J, Pedersen, Ron, Dorries, Kathleen M, Ninan, Philip T
• Format: Journal Article
• Language: English
• Published: United States 01.04.2013
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation - adverse effects; Antidepressive Agents, Second-Generation - therapeutic use; Cyclohexanols - adverse effects; Cyclohexanols - therapeutic use; Depressive Disorder, Major - diagnosis; Depressive Disorder, Major - drug therapy; Depressive Disorder, Major - psychology; Double-Blind Method; Female; Fluoxetine - adverse effects; Fluoxetine - therapeutic use; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory - statistics & numerical data; Psychometrics; Secondary Prevention; Sexual Dysfunction, Physiological - chemically induced; Sexual Dysfunction, Physiological - diagnosis; Sexual Dysfunction, Physiological - psychology; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult; United States

The incidence of treatment-emergent sexual dysfunction in the acute and continuation phases of the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study was assessed. Adult outpatients with recurrent major depressive disorder were randomly assigned to recei...